A detailed history of Excalibur Management Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Excalibur Management Corp holds 39,885 shares of JNJ stock, worth $5.83 Million. This represents 2.68% of its overall portfolio holdings.

Number of Shares
39,885
Previous 39,200 1.75%
Holding current value
$5.83 Million
Previous $6.14 Million 2.69%
% of portfolio
2.68%
Previous 2.91%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $106,325 - $111,476
685 Added 1.75%
39,885 $6.31 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $54,745 - $59,738
376 Added 0.97%
39,200 $6.14 Million
Q3 2023

Nov 09, 2023

BUY
$155.75 - $174.48 $17,755 - $19,890
114 Added 0.29%
38,824 $6.05 Million
Q2 2023

Aug 08, 2023

SELL
$154.35 - $166.11 $1,852 - $1,993
-12 Reduced 0.03%
38,710 $6.41 Million
Q1 2023

May 05, 2023

SELL
$151.05 - $180.26 $2,416 - $2,884
-16 Reduced 0.04%
38,722 $6 Million
Q4 2022

Feb 10, 2023

SELL
$160.2 - $179.79 $64,079 - $71,916
-400 Reduced 1.02%
38,738 $6.84 Million
Q3 2022

Nov 04, 2022

BUY
$161.33 - $179.52 $43,559 - $48,470
270 Added 0.69%
39,138 $6.39 Million
Q2 2022

Jul 25, 2022

SELL
$168.19 - $186.01 $226,047 - $249,997
-1,344 Reduced 3.34%
38,868 $6.9 Million
Q1 2022

May 03, 2022

BUY
$158.14 - $179.59 $17,869 - $20,293
113 Added 0.28%
40,212 $7.13 Million
Q4 2021

Feb 10, 2022

BUY
$155.93 - $173.01 $130,201 - $144,463
835 Added 2.13%
40,099 $6.86 Million
Q3 2021

Oct 28, 2021

SELL
$161.5 - $179.47 $6,460 - $7,178
-40 Reduced 0.1%
39,264 $6.34 Million
Q2 2021

Jul 26, 2021

SELL
$159.48 - $171.07 $280,525 - $300,912
-1,759 Reduced 4.28%
39,304 $6.48 Million
Q1 2021

May 03, 2021

BUY
$153.07 - $170.48 $43,165 - $48,075
282 Added 0.69%
41,063 $6.75 Million
Q4 2020

Jan 26, 2021

SELL
$137.11 - $157.38 $160,692 - $184,449
-1,172 Reduced 2.79%
40,781 $6.42 Million
Q3 2020

Nov 02, 2020

SELL
$140.38 - $153.83 $187,266 - $205,209
-1,334 Reduced 3.08%
41,953 $6.25 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $69,815 - $84,286
-542 Reduced 1.24%
43,287 $6.09 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $135,590 - $187,867
1,220 Added 2.86%
43,829 $5.75 Million
Q4 2019

Feb 04, 2020

BUY
$127.5 - $146.44 $812,430 - $933,115
6,372 Added 17.58%
42,609 $6.22 Million
Q3 2019

Oct 21, 2019

SELL
$126.95 - $142.14 $126,823 - $141,997
-999 Reduced 2.68%
36,237 $4.69 Million
Q2 2019

Jul 26, 2019

SELL
$131.15 - $144.24 $86,559 - $95,198
-660 Reduced 1.74%
37,236 $5.19 Million
Q1 2019

Apr 24, 2019

SELL
$125.72 - $139.79 $84,483 - $93,938
-672 Reduced 1.74%
37,896 $5.3 Million
Q4 2018

Jan 29, 2019

SELL
$122.84 - $147.84 $585,086 - $704,161
-4,763 Reduced 10.99%
38,568 $4.98 Million
Q3 2018

Oct 25, 2018

SELL
$121.58 - $142.88 $730,695 - $858,708
-6,010 Reduced 12.18%
43,331 $5.99 Million
Q2 2018

Jul 26, 2018

BUY
$119.4 - $131.76 $1,671 - $1,844
14 Added 0.03%
49,341 $5.99 Million
Q1 2018

Apr 23, 2018

SELL
$125.1 - $148.14 $64,426 - $76,292
-515 Reduced 1.03%
49,327 $6.32 Million
Q4 2017

Jan 22, 2018

SELL
$131.22 - $143.62 $166,255 - $181,966
-1,267 Reduced 2.48%
49,842 $6.96 Million
Q3 2017

Oct 25, 2017

BUY
$129.47 - $135.38 $6.62 Million - $6.92 Million
51,109
51,109 $6.65 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Excalibur Management Corp Portfolio

Follow Excalibur Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Excalibur Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Excalibur Management Corp with notifications on news.